• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆置换治疗重症肌无力患者外周血自然杀伤细胞细胞毒性抑制。

Inhibition of peripheral blood natural killer cell cytotoxicity in patients with myasthenia gravis treated with plasmapheresis.

机构信息

Department of Biochemistry, College of Medicine, Taipei Medical University, Taipei, Taiwan.

出版信息

Eur J Neurol. 2011 Nov;18(11):1350-7. doi: 10.1111/j.1468-1331.2011.03424.x. Epub 2011 May 7.

DOI:10.1111/j.1468-1331.2011.03424.x
PMID:21554496
Abstract

BACKGROUND AND PURPOSE

Myasthenia gravis (MG) is an autoimmune disorder that may involve natural killer (NK) cells. Although NK cells are part of the innate immune system, they also influence adaptive immune responses. Double-filtration plasmapheresis (DFP) is an effective therapy for MG crisis. Thus, we examined the effects of DFP on the cytotoxicity of NK cells.

METHODS

A total of 20 patients with MG and 16 healthy controls were recruited for the study. Ficoll-Paque-isolated peripheral blood mononuclear cells (PBMCs) and K562 cells were used as the effector and target cells, respectively. NK cell cytotoxicity was analyzed using flow cytometry immediately before and after DFP and upon course completion.

RESULTS

Double-filtration plasmapheresis treatment decreased significantly the NK cell cytotoxicity in patients with MG, especially in good responders, those who were positive for acetylcholine receptor (AChR) antibodies, and those receiving immunosuppressants.

CONCLUSIONS

The decrease in NK cell cytotoxicity after DFP and the decline of AChR antibody titer were observed in good responders indicating that this could benefit patients with MG.

摘要

背景与目的

重症肌无力(MG)是一种自身免疫性疾病,可能涉及自然杀伤(NK)细胞。尽管 NK 细胞是先天免疫系统的一部分,但它们也会影响适应性免疫反应。双重滤过血浆置换(DFP)是治疗 MG 危象的有效方法。因此,我们研究了 DFP 对 NK 细胞细胞毒性的影响。

方法

共招募 20 例 MG 患者和 16 例健康对照者进行研究。Ficoll-Paque 分离的外周血单个核细胞(PBMC)和 K562 细胞分别作为效应细胞和靶细胞。在 DFP 治疗前后和疗程结束时,使用流式细胞术分析 NK 细胞的细胞毒性。

结果

DFP 治疗显著降低了 MG 患者的 NK 细胞细胞毒性,尤其是在良好反应者、乙酰胆碱受体(AChR)抗体阳性者和接受免疫抑制剂治疗者中。

结论

在良好反应者中观察到 DFP 后 NK 细胞细胞毒性下降和 AChR 抗体滴度下降,表明这可能对 MG 患者有益。

相似文献

1
Inhibition of peripheral blood natural killer cell cytotoxicity in patients with myasthenia gravis treated with plasmapheresis.血浆置换治疗重症肌无力患者外周血自然杀伤细胞细胞毒性抑制。
Eur J Neurol. 2011 Nov;18(11):1350-7. doi: 10.1111/j.1468-1331.2011.03424.x. Epub 2011 May 7.
2
A decrease in the percentage of CD3+ cells is correlated with clinical improvement during plasmapheresis in patients with myasthenia gravis.在重症肌无力患者的血浆置换过程中,CD3+细胞百分比的下降与临床改善相关。
Artif Organs. 2013 Feb;37(2):211-6. doi: 10.1111/j.1525-1594.2012.01531.x. Epub 2012 Sep 30.
3
An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.一种改进的基于流式细胞术的自然杀伤细胞细胞毒性检测方法,该方法涉及对效应细胞进行钙黄绿素 AM 染色。
Ann Clin Lab Sci. 2012 Winter;42(1):42-9.
4
Experience in the treatment of myasthenia gravis with double filtration plasmapheresis.双重过滤血浆置换治疗重症肌无力的经验
Chang Gung Med J. 2000 Feb;23(2):80-6.
5
MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis.重症肌无力患者在连续多次血浆置换治疗期间MuSK抗体的清除情况。
J Neurol Sci. 2007 Dec 15;263(1-2):191-3. doi: 10.1016/j.jns.2007.05.033. Epub 2007 Jun 28.
6
Pulmonary function study of myasthenia-gravis patients treated with double-filtration plasmapheresis.接受双重过滤血浆置换治疗的重症肌无力患者的肺功能研究。
J Clin Apher. 2003;18(3):125-8. doi: 10.1002/jca.10067.
7
Comparing individual NK cell activity in vitro.比较体外单个自然杀伤细胞的活性。
Curr Protoc Immunol. 2013;Chapter 14:Unit 14.32.. doi: 10.1002/0471142735.im1432s100.
8
Peripheral blood natural killer (NK) cell function in healthy adults assessed using the target-induced NK loss (TINKL) assay.采用靶细胞诱导自然杀伤细胞耗竭(TINKL)检测法评估健康成年人外周血自然杀伤(NK)细胞功能。
J Immunol Methods. 2013 Jun 28;392(1-2):68-70. doi: 10.1016/j.jim.2013.03.010. Epub 2013 Apr 6.
9
Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis.重症肌无力患者血浆置换过程中血清细胞因子水平的变化。
Eur J Neurol. 2009 Dec;16(12):1318-22. doi: 10.1111/j.1468-1331.2009.02729.x. Epub 2009 Jul 14.
10
Implementation of the EGFP-K562 flow cytometric NK test: determination of NK cytotoxic activity in healthy elderly volunteers before and after feeding.增强绿色荧光蛋白标记的K562细胞流式细胞术自然杀伤细胞检测的实施:健康老年志愿者进食前后自然杀伤细胞细胞毒性活性的测定
Cytometry A. 2006 Sep 1;69(9):992-8. doi: 10.1002/cyto.a.20301.

引用本文的文献

1
Longitudinal Improvement in Respiratory Function Following Plasma Exchange in Patients with Severe Myasthenia Gravis.重症肌无力患者血浆置换后呼吸功能的纵向改善
Neurocrit Care. 2025 Apr 3. doi: 10.1007/s12028-025-02238-9.
2
Nonlinear relationship between circulating natural killer cell count and 1-year relapse rates in myasthenia gravis: a retrospective cohort study.重症肌无力患者循环自然杀伤细胞计数与1年复发率之间的非线性关系:一项回顾性队列研究
PeerJ. 2024 Dec 6;12:e18562. doi: 10.7717/peerj.18562. eCollection 2024.
3
Type 2 hypersensitivity disorders, including systemic lupus erythematosus, Sjögren's syndrome, Graves' disease, myasthenia gravis, immune thrombocytopenia, autoimmune hemolytic anemia, dermatomyositis, and graft-versus-host disease, are THαβ-dominant autoimmune diseases.
2 型超敏反应性疾病,包括系统性红斑狼疮、干燥综合征、格雷夫斯病、重症肌无力、免疫性血小板减少症、自身免疫性溶血性贫血、皮肌炎和移植物抗宿主病,都是 THαβ 主导的自身免疫性疾病。
Virulence. 2024 Dec;15(1):2404225. doi: 10.1080/21505594.2024.2404225. Epub 2024 Sep 16.
4
Clinical and immune-related factors associated with exacerbation in adults with well-controlled generalized myasthenia gravis.与成人控制良好的全身性重症肌无力恶化相关的临床和免疫相关因素。
Front Immunol. 2023 May 17;14:1177249. doi: 10.3389/fimmu.2023.1177249. eCollection 2023.
5
miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus.miR-183-5p 是系统性红斑狼疮的潜在分子标志物。
J Immunol Res. 2021 May 6;2021:5547635. doi: 10.1155/2021/5547635. eCollection 2021.
6
Update on ocular myasthenia gravis in Taiwan.台湾眼肌型重症肌无力最新情况
Taiwan J Ophthalmol. 2018 Apr-Jun;8(2):67-73. doi: 10.4103/tjo.tjo_39_17.
7
Effects of combined traditional Chinese medicine with immunosuppressive agents for patients with myasthenia gravis.中药联合免疫抑制剂治疗重症肌无力患者的疗效
Int J Clin Exp Med. 2015 Oct 15;8(10):19044-50. eCollection 2015.
8
Clinical characteristics and therapeutic evaluation of childhood myasthenia gravis.儿童重症肌无力的临床特征与治疗评估
Exp Ther Med. 2015 Apr;9(4):1363-1368. doi: 10.3892/etm.2015.2256. Epub 2015 Feb 3.
9
Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma.肝癌细胞因子诱导的杀伤细胞免疫治疗中不同外周血单个核细胞分离方法的比较研究
Tumour Biol. 2015 Apr;36(4):2299-307. doi: 10.1007/s13277-014-2837-5. Epub 2014 Nov 24.
10
Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker.在重症肌无力中循环 miRNA:miR-150-5p 作为一种新的潜在生物标志物。
Ann Clin Transl Neurol. 2014 Jan;1(1):49-58. doi: 10.1002/acn3.24. Epub 2013 Dec 30.